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Crystal structures of reduced and oxidized DsbA: investigation of
domain motion and thiolate stabilization
Luke W Guddat1, James CA Bardwell2 and Jennifer L Martin1*
Background:  The redox proteins that incorporate a thioredoxin fold have
diverse properties and functions. The bacterial protein-folding factor DsbA is
the most oxidizing of the thioredoxin family. DsbA catalyzes disulfide-bond
formation during the folding of secreted proteins. The extremely oxidizing nature
of DsbA has been proposed to result from either domain motion or stabilizing
active-site interactions in the reduced form. In the domain motion model, hinge
bending between the two domains of DsbA occurs as a result of redox-related
conformational changes.
Results:  We have determined the crystal structures of reduced and oxidized
DsbA in the same crystal form and at the same pH (5.6). The crystal structure
of a lower pH form of oxidized DsbA has also been determined (pH 5.0). These
new crystal structures of DsbA, and the previously determined structure of
oxidized DsbA at pH 6.5, provide the foundation for analysis of structural
changes that occur upon reduction of the active-site disulfide bond.
Conclusions:  The structures of reduced and oxidized DsbA reveal that hinge
bending motions do occur between the two domains. These motions are
independent of redox state, however, and therefore do not contribute to the
energetic differences between the two redox states. Instead, the observed
domain motion is proposed to be a consequence of substrate binding.
Furthermore, DsbA’s highly oxidizing nature is a result of hydrogen bond,
electrostatic and helix-dipole interactions that favour the thiolate over the
disulfide at the active site.
Introduction
DsbA is one of a family of disulfide oxidoreductase pro-
teins that share a common domain structure, the thiore-
doxin fold [1]. In addition to the bacterial disulfide catalyst
DsbA, the thioredoxin-fold family includes the eukaryo-
tic protein disulfide isomerase (PDI) and the ubiquitous
reductants, thioredoxin and glutaredoxin. Numerous other
proteins of varying sequence length that catalyze a range of
disulfide exchange reactions [2–5] incorporate the classic
thioredoxin active-site motif Cys–X–X–Cys (and presum-
ably the thioredoxin fold) in divergent but recognizably
homologous sequences.
Within the subset of thioredoxin fold proteins that catalyze
disulfide-exchange reactions, and for which three-dimen-
sional structures are known, the thioredoxin domain is
utilised in a variety of ways to perform a wide range of re-
dox reactions. Thus, thioredoxin and glutaredoxin include
only the thioredoxin domain in their three-dimensional
structure — they are single-domain monomeric proteins.
DsbA is also a monomer, but is twice the size of gluta-
redoxin and thioredoxin. The structure of DsbA incorpo-
rates both a thioredoxin domain and a helical domain,
which is inserted into the thioredoxin domain (Figure 1;
[6]). Finally, PDI is dimeric with each 57 kDa monomer
organised into four thioredoxin domains [7]. The first two
proteins, glutaredoxin and thioredoxin, are both reducing,
but thioredoxin is a more general protein reductant than
glutaredoxin [8]. In contrast, DsbA and PDI are both oxidi-
zing proteins. Both have broad substrate specificity; DsbA
functions almost exclusively as an oxidant, PDI can also
catalyze disulfide rearrangement [9].
The common thioredoxin folds in each of these four pro-
teins are very similar [1,7,10], incorporating a four-stranded
β sheet and three helices. One of the two active-site cys-
teines, the more N-terminal of the two in sequence, pro-
trudes from the surface of the thioredoxin-like proteins. In
all these proteins this cysteine is the reactive cysteine that
interacts with the substrate cysteine.
Despite the high degree of structural similarity, the thiore-
doxin-like proteins vary widely in their oxidizing power.
Because the redox power of these proteins closely reflects
their function, an important goal in analyzing the function
of these proteins is the elucidation of how such a wide
variation in redox potential is produced within equivalent
structural frameworks. 
Addresses:  1Centre for Drug Design and
Development, University of Queensland, Brisbane,
QLD, 4072, Australia. 2Department of Biology,
University of Michigan, Ann Arbor, MI,
48109-1048, USA.
*Corresponding author.
E-mail:  j.martin@mailbox.uq.edu.au
Key words: disulfide bond, DsbA, protein folding,
protein structure, thioredoxin fold
Received:  16 March 1998
Revisions requested:  14 April 1998
Revisions received:  20 April 1998
Accepted:  20 April 1998
Structure  15 June 1998, 6:757–767
http://biomednet.com/elecref/0969212600600757
© Current Biology Ltd ISSN 0969-2126
Research Article 757
DsbA functions as a protein oxidant in the bacterial peri-
plasm and is by far the most oxidizing of the thioredoxin-
like proteins, with a redox equilibrium constant for the
reaction with glutathione of 0.1 mM [11,12]. In compari-
son, the value for PDI is ~1 mM [13,14] and for the reduc-
ing protein thioredoxin it is 10 M [15]. Thus, DsbA
strongly favours formation of oxidized glutathione, whereas
the reverse is true for thioredoxin. The extreme nature
of DsbA’s redox potential should simplify the recognition
of redox determinants of this protein in comparison to
thioredoxin, the most reducing of these proteins.
We are assisted in our work by a large amount of biochem-
ical, structural and genetic information on DsbA. DsbA
has two unusual properties that are thought to contribute
to its highly oxidizing nature. First, although disulfides
generally stabilize proteins, oxidized DsbA is less stable
than reduced DsbA [12,16]. Second, the pKa of the acces-
sible cysteine (Cys30) in the active site of DsbA is strongly
perturbed from the normal value of ~9 to a very low value
of 3.5 [17,18]. This implies that at physiological pH, Cys30
is fully ionized to the thiolate form.
The unusual stability of reduced DsbA, and hence its
strongly oxidizing nature, may be explained either by elec-
trostatics at the active site or by domain motion — or a
combination of both. In the electrostatic model, the
reduced form of DsbA is energetically preferred through
stabilization of the Cys30 thiolate [17,19]. In the domain
motion model, the energy difference between oxidized
and reduced DsbA is a result of redox-dependent confor-
mational changes [20,21] and provides the thermodynamic
drive favoring transfer of disulfide from DsbA to substrate.
We have previously proposed the possibility of hinge
bending motion in DsbA and have identified a β turn con-
necting the two domains as a possible hinge point for
domain motion [20].
The question of why DsbA is so oxidizing is addressed
here at the molecular level by a structural comparison of
oxidized DsbA with reduced DsbA. We present an analysis
of two independent structures of reduced DsbA and five
independent structures of oxidized DsbA. A comparison of
these structures reveals that local conformational changes
occur at the active site in response to active-site disulfide
reduction, resulting in a network of stabilizing interactions
around the active-site thiolate. Domain motion is not corre-
lated with this redox state change, but may be associated
with substrate binding near the active site.
Results
Redox structures of DsbA
To elucidate the reasons for DsbA’s extremely oxidizing
redox potential we have determined the crystal structure of
reduced DsbA and compared it with structures of oxidized
DsbA. We have two independent structures of reduced
DsbA (non-crystallographic symmetry-related structures),
and five independent structures of oxidized DsbA, three of
which are from two new crystal forms. These crystal struc-
tures, derived from varying crystallization conditions (pH
range 5–6.5) and with very different crystal lattice contacts,
provide an ideal platform for understanding how the redox
state affects the conformation and function of DsbA.
The previously reported crystal structure of oxidized DsbA
(OX1; [6,20]) was determined at pH 6.5 from a monoclinic
crystal form, with two molecules in the asymmetric unit
(OX1A and OX1B). The three newly determined crystal
structures are: reduced DsbA (RED) at pH 5.6 in an
orthorhombic crystal form, including two copies of the
protein in the asymmetric unit (REDA and REDB); oxi-
dized DsbA (OXR), which was produced from a crystal of
reduced DsbA that was oxidized by withholding addition of
reducing agent after crystal formation (this oxidized DsbA
structure is in the same crystal form and at the same pH as
the reduced DsbA structure and also has two independent
copies in the asymmetric unit, OXRA and OXRB); and oxi-
dized DsbA (OX2) at pH 5.0 in a monoclinic crystal form,
with one molecule in the asymmetric unit.
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Figure 1
A schematic representation of DsbA with helices shown as coils and
strands as arrows. The thioredoxin domain is in green and the helical
domain is in blue. The N and C termini are labeled and the active-site
Cys30 sulfur atom is shown as a yellow CPK sphere. The putative
peptide-binding groove is bounded by the active-site helix α1/α1′ and
the flexible loop between β5 and α7. This figure was generated using
MOLSCRIPT v2.0.1 [52] and Raster3D [53,54].
Crystallographic and geometric statistics for the three new
crystal structures are given in Tables 1 and 2. Figure 2 shows
the electron density in the active-site region of reduced
and oxidized DsbA from the orthorhombic crystal form.
A comparison of DsbA redox structures
The structural similarity of each of the DsbA structures
described above was analyzed pairwise by measuring the
root mean square deviation (rmsd) for Cα atoms of all
residues (Table 3, normal text). Most pairs of structures
were very similar, having rmsd values for all Cα atoms of
0.5–0.6 Å. The largest difference between any pair of
structures is 0.92 Å. This difference is for the comparison
of a reduced and oxidized pair of structures determined at
the same pH (REDA and OXRB). In contrast, a compari-
son of the two reduced DsbA structures in the same
crystal form and at the same pH (REDA and REDB)
gives an rmsd of 0.55 Å. This result on its own could be
taken to indicate that a significant conformational change
occurs upon oxidation of the active-site cysteines. Other
lines of evidence do not support this, however. First, the
other three pairs of reduced and oxidized structures at the
same pH have much lower rmsd values (< 0.57 Å).
Second, three of the four pairs of DsbA structures with
the lowest rmsd (< 0.5 Å) are for comparisons of oxidized
and reduced DsbA structures over a wide range of pH
values. Finally, two of the four pairs of DsbA structures
having the largest rmsd values (> 0.90 Å) are for compar-
isons of oxidized DsbAs. Overall, these results show that
there is no large structural change upon reduction of the
active-site disulfide of DsbA.
We also determined how similar the isolated thioredoxin
domains in the different crystal forms were to each other
and how similar the helical domains were to each other
(Table 3, bold text). The results from this individual
domain comparison suggest that the domains are very
similar between the different crystal structures and that
there is no correlation between a lower rmsd and the same
redox state. For example, the thioredoxin domains of a
reduced and oxidized pair of structures (REDA and OX2)
are the most similar of any pair (rmsd 0.32 Å).
The pairs of structures with the largest rmsd values in the
overall comparison had significantly lower rmsd values for
the single domain comparisons (see for example REDA
and OX1A). Further analysis of all the structures revealed
that the domains of DsbA can move relative to one
another, in a hinge bending motion (Figure 3).
Domain motion does not correlate with redox state
Previously, we have hypothesised that the two domains of
DsbA can move relative to one another and that this could
be a means of stabilizing the reduced relative to oxidized
DsbA [20,21]. A putative hinge region was identified: a loop
of residues (Phe63–Met64–Gly65–Gly66) forming a type IV
β turn connecting the thioredoxin and helical domains. The
other connection between the two domains of DsbA is helix
α6. This helix corresponds to helix α3 in thioredoxin, but is
extended by two turns in DsbA and can be considered to be
part of either domain in DsbA (Figure 1). Using the pro-
gram HINGEFIND [22], we analyzed the hinge bending
that occurs between the two domains for each pair of struc-
tures. We found that the hinge bending angle between the
helical domain and the thioredoxin domain varies by as
much as 7° among the seven DsbA structures. The three
pairs of non-crystallographic symmetry-related DsbA struc-
tures (OX1A and OX1B, OXRA and OXRB, REDA and
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Table 1
Crystallographic data.
RED OXR OX2
Unit cell
a 88.9 89.4 38.5
b 83.4 83.8 51.4
c 58.3 58.9 42.5
α 90.0 90.0 90.0
β 90.0 90.0 103.1
γ 90.0 90.0 90.0
Space group P21212 P21212 P21
Solvent (%) 49 49 37
Molecules in asymmetric unit 2 2 1
Resolution range 50–2.7 50–2.7 50–2.0
Observations (I > 1σ(I)) 18,501 43,081 38,303
Unique reflections (I > 1σ(I)) 9,160 10,864 10,434
Outer shell 2.8–2.7 2.8–2.7
2.07–2.0
Rsym* (%) 11.8 8.3 4.6
Rsym* (outer shell) (%) 29.4 29.8 15.3
I/σ(I) 7.0 13.0 16.0
I/σ(I) (outer shell) 2.2 3.2 7.4
Completeness (%) 73.6 86.1 94.2
Completeness (outer shell; %) 56.1 69.9 81.6
*Rsym = Σ|I – 〈I〉|/Σ〈I〉.
Table 2
Crystallographic refinement statistics.
RED OXR OX2
Resolution range (Å) 50–2.7 50–2.7 50–2.0
Number of reflections (F > 1σF) 8,931 10,710 10,332
R-factor* 0.233 0.261 0.182
R-free† 0.285 0.308 0.227
Number of waters 16 25 90
Average B-factor (Å2) 31.2 24.2 23.6
Rmsd from ideal
Bond length (Å) 0.004 0.004 0.005
Bond angle (°) 0.89 0.94 1.00
Dihedral angle (°) 22.2 23.2 22.4
Improper angle (°) 0.87 0.89 0.96
Ramachandran statistics
Residues in most favoured region (%) 89.0 88.3 93.4
Residues in disallowed regions (%) 0 0 0
*R-factor = Σ | Fo–Fc |/ Σ Fo. †R-free as defined by Brünger [48].
REDB), for which one might expect the smallest domain-
angle differences, have hinge bend angles of 3.5–4°. The
largest values (6–7°) represent a closure of the helical
domain of REDA or OX2 when compared with OX1A,
OX1B or OXRB. In contrast, one of the smallest hinge
bend angles (1.5°) occurs for the comparison of REDA and
OX2 — structures of different redox forms, crystallized at
different pH and in different crystal lattices. These results
confirm that there is no correlation between redox state and
domain movement in these crystal structures.
Domain closure may occur upon peptide–groove interaction
If the domain motion in DsbA is not redox related, what
causes the hinge bending in these different structures?
The reason appears to be crystal contacts that specifically
involve the putative peptide-binding groove (bound by
the active-site helix α1/α1′ and the loop connecting strand
β5 and helix α7). In OX2, these interactions are formed
between the crystallographic symmetry-related residues
Ser128*–Phe129*–Val130* and residues of the groove
(Figure 4). Phe129* binds deep within the peptide groove
and forms hydrophobic interactions with residues Pro163,
Phe174 and the sidechain carbons of Gln164 and Thr168.
In addition, symmetry-related Val130* forms hydrophobic
interactions with Met171 and Thr168.
Similarly, in REDA the symmetry-related residues
Val196A*–Gln97A*–Lys98A*–Thr99A*–Gln100A* interact
with the peptide-binding region and in REDB there are
interactions with Arg103A*, Ser104A*, Asp172B* and
Val173B*. In both reduced structures, however, the sym-
metry-related residue interactions with the peptide groove
are not as deep as those observed in OX2. Curiously, the
two oxidized DsbA structures OXRA and OXRB, derived
from crystals of reduced DsbA that were allowed to oxidize,
have somewhat different crystal contacts to the equivalent
REDA and REDB structures (cell edges increase by ~0.5 Å
in OXR compared with RED, Table 1). The altered crystal
contacts result in small differences (~3°) in the hinge bend
angle for OXRA/REDA and OXRB/REDB. These differ-
ences result from a re-packing of the symmetry-related mol-
ecules in OXR compared with RED to accommodate local
structural changes at the active site (see below).
The structural consequence of interactions between sym-
metry-related residues and the peptide groove in DsbA is
a widening of the groove, resulting from an increased sep-
aration of the flexible loop and the active-site helix. The
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Table 3
A comparison of oxidized and reduced DsbA. 
OX1A OX1B OX2 OXRA OXRB REDA REDB
OX1A 0.35 0.59 0.50 0.39 0.54 0.35
0.38 0.35 0.40 0.35 0.40 0.32
OX1B 0.57 0.45 0.40 0.39 0.41 0.35
0.36 0.39 0.46 0.38 0.34
OX2 0.91 0.69 0.45 0.58 0.32 0.43
0.42 0.38 0.27 0.25
OXRA 0.63 0.56 0.62 0.47 0.42 0.43
0.45 0.39 0.41
OXRB 0.46 0.59 0.91 0.62 0.52 0.38
0.45 0.41
REDA 0.90 0.73 0.38 0.57 0.92 0.39
0.30
REDB 0.55 0.48 0.54 0.45 0.56 0.55
Normal text, rmsd (Å) for 186 Cα atoms (residues 3–188); bold text,
rmsd (Å) for 95 Cα atoms in the thioredoxin domain (residues 7–14,
19–63, 139–166, 173–186) and 75 Cα atoms in the helical domain
residues (64–138).
Figure 2
An electron density map (2Fo–Fc, 1σ) for
residues Cys30–Pro31–His32–Cys33 at the
active site of DsbA showing (a) the reduced
thiols in REDB and (b) the disulfide bond in
OXRB. This figure was generated using
Setor v5.0 [55].
movement of the active-site helix transmits to the helical
domain and the overall effect is a small but significant hinge
bending closure of the helical domain with respect to the
thioredoxin domain. This hinge closing movement may be
biologically relevant because the interactions observed in
the crystal could be representative of the interactions that
occur between substrate and DsbA. Thus, an interaction
between unfolded polypeptide substrate and DsbA could
well involve hydrophobic interactions like those observed
in the symmetry-related contacts and could therefore result
in domain closure.
Thiolate stabilization in reduced DsbA
As described above, no large conformational change occurs
upon disulfide reduction in the crystal structures of DsbA
described here. Where differences in domain orientation
are observed, these correlate with crystal contacts involv-
ing peptide–groove interactions, rather than with the
redox state of the protein. What then are the differences
between the oxidized and reduced structures of DsbA that
could account for the stability difference between the two
redox states?
The very low pKa of Cys30 means that this thiol group is
ionized (thiolate) when DsbA is in the reduced form. The
crystal structure of reduced DsbA, determined at pH 5.6,
provides us with two independent views — REDA and
REDB — of this Cys30 thiolate redox form. In compari-
son with the oxidized DsbA structures, the sidechain of
Cys30 in both REDA and REDB moves to a much greater
extent (up to a 1 Å shift of Cys30 Sγ) than that of Cys33
(Figure 5). In addition, the surface accessibility of Cys30
Sγ increases by 5–10% whereas Cys33 Sγ is completely
buried in both redox states.
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Figure 3
A stereo view of the superimposition of
backbone Cα traces of the five oxidized and
two reduced DsbA crystal structures. (a) The
superimposition using residues from the
thioredoxin domain (7–14, 19–63, 139–166
and 173–186) and (b) the superimposition
using residues from the helical domain
(64–138). The active-site Cys30 sulfur atom
is shown as a CPK sphere. The flexible loop,
indicated by an asterisk, forms one edge of
the putative peptide-binding groove. The two
domain connections (the β-turn, indicated by
a hash sign, and helix α6) are also indicated.
This figure was generated using MOLSCRIPT
v2.0.1 [52].
#*
α6
* #
α6
α6
* #
α6
#*
Structure
(a)
(b)
Figure 4
Symmetry-related contact in the OX2 crystal structure at the proposed
peptide-binding groove of DsbA. The groove is formed between the
active-site helix (α1) on the left and the β5 strand–loop–α7 helix on the
right. The symmetry-related atoms Ser128*–Phe129*–Val130* are
shown in a blue ball-and-stick representation, with Phe129* labeled
(F129*). The active-site Cys30 sulfur atom is shown as a yellow CPK
sphere. This figure was generated using MOLSCRIPT v2.0.1 [52] and
Raster3D [53,54].
In both REDA and REDB, the Cys30 thiolate is stabi-
lized by several interactions (Table 4, Figure 6). One of
these is a hydrogen bond formed between the Cys30 Sγ
thiolate and the thiol of Cys33. Two other hydrogen bonds
further stabilize the Cys30 Sγ thiolate; these are interac-
tions with the backbone amide nitrogens of His32 and
Cys33. In the oxidized structures of DsbA, the hydrogen
bond between Cys30 Sγ and the Cys33 amide is present,
but the interaction with the His32 amide is absent.
Mutagenesis studies show that His32 is important for the
redox stability profile of DsbA [18]. It has been suggested
that the Cys30 Sγ thiolate is stabilized by a favourable
electrostatic interaction with the sidechain of His32. The
structures of reduced DsbA described here lend support
to this hypothesis because they indicate a movement of
His32 towards the Cys30 sidechain, compared with the
oxidized structures (Figure 5). In the case of REDA, the
Cys30 Sγ and His32 Nδ1 atoms are within hydrogen-
bonding distance (3.6 Å, Figure 6). For REDB this dis-
tance is 4.5 Å, but is nonetheless 1–2.5 Å shorter than the
oxidized DsbA crystal structures. Strangely, the most dra-
matic difference in the His32 conformation in all these
crystal structures is for the comparison of REDA and
OXRA — the reduced and oxidized forms of DsbA from
the same crystal form. For these two structures, the His32
χ1 sidechain dihedral differs by 120° (Figure 5). This
difference gives rise to different crystal packing in this
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Figure 5
A stereo view of the superimposition of the
active-site residues Cys30–Pro31–His32–
Cys33 for the five oxidized and two reduced
DsbA structures. The reduced DsbA
structures (REDA, REDB) are shown in green
(His32 of REDA is closer to the Cys30
sidechain than that of REDB) and the
equivalent oxidized DsbA structures (OXRA,
OXRB) are shown in yellow (His32 of OXRA
is farthest from the Cys30 sidechain). The two
OX1 structures are in light blue and the low
pH oxidized structure (OX2) is in orange. This
figure was generated using MOLSCRIPT
v2.0.1 [52] and Raster3D [532,54].
Figure 6
The active-site residues of REDA, shown in the same orientation as
that used in Figure 5. The atoms Cys30 Sγ, His32 N and Nδ1, Cys33
N and Sγ are shown as spheres. Hydrogen bond interactions with
Cys30 thiolate are shown as dashed lines. The interaction between
Cys30 thiolate and Cys33 thiol is shown as a dotted line. Distances
for these interactions are shown in Å. This figure was generated using
MOLSCRIPT v2.0.1 [52].
His32
Pro31
Cys30
Cys33
3.5
3.6
3.6
3.6
Structure
Table 4
Interatomic distances* at the active site.
OX1A OX1B OX2 OXRA OXRB REDA REDB
30Sγ–33Sγ 2.0 2.0 2.0 2.0 2.0 3.5 3.4
30Sγ–32N 4.0 4.1 4.0 3.8 3.8 3.6 3.4
30Sγ–33N 3.1 3.2 3.2 3.0 3.1 3.6 3.3
30Sγ–32Nδ1 5.8 7.0 6.8 5.6 6.6 3.6 4.5
33Sγ–27N 3.9 4.0 3.8 3.9 3.7 3.7 3.8
33Sγ–27O 3.9 4.1 3.9 3.9 3.8 4.0 4.0
33Sγ–30O 4.0 4.1 3.9 3.8 3.9 4.3 4.5
*Distances are given in Å. The hydrogen bond distance between two
thiol groups is usually 3.8 Å; between thiol and nitrogen or oxygen
atoms, the hydrogen bond distance is usually 3.3–3.6 Å [29–31].
region and results in a different domain hinge angle, as
described above.
A comparison with thioredoxin
To investigate why the active-site disulfide is destabilizing
in DsbA but stabilizing in structurally related proteins, we
also compared the structures of the very oxidizing DsbA
with oxidized and reduced structures of the most reducing
member of the family, thioredoxin. Three groups have
determined structures for the two redox forms of thiore-
doxin. The NMR solution structures of reduced and oxi-
dized Escherichia coli [23] and human [24] thioredoxin are
available. Furthermore, crystal structures of the two redox
forms of human thioredoxin are also published [25]. Coor-
dinates for all these structures are available from the
Protein Data Bank [26].
As we observed for DsbA, there are no large conformational
differences between the reduced and oxidized structures of
thioredoxin. The structural differences that are observed,
are small and localized to the active site. Thus, upon active-
site reduction, the NMR structures of E. coli thioredoxin
and the crystal structures of human thioredoxin show a
larger change in position of the more N-terminal cysteine in
the active site compared with the C-terminal cysteine. In
the NMR structure of human thioredoxin, however, a larger
change is observed for the more C-terminal cysteine.
In the crystal structure of reduced DsbA, we observe a
hydrogen bond between the sidechain sulfurs of the two
active-site cysteines. Similarly, in the NMR structure of
E. coli thioredoxin and the crystal structure of human
thioredoxin, a hydrogen bond of 3.8–3.9 Å is observed
between the sidechain of the Cys30 equivalent and the
thiol of the Cys33 equivalent [23,25]. In the NMR struc-
ture of human thioredoxin, however, the average distance
for this bond is a very short 3.1 Å [24]. This may be the
result of a soft non-bonded potential used in the structure
refinement [23].
The crystal structures of both reduced and oxidized DsbA
reveal a hydrogen bond between Cys30 and the amide
nitrogen of Cys33. Curiously, the interaction with the
Cys33 equivalent mainchain amide is observed only in the
oxidized forms of the NMR structure of E. coli and the
crystal structure of human thioredoxin, and is absent in
the corresponding reduced structures. This hydrogen
bond is observed in both oxidized and reduced forms of
the NMR structures of human thioredoxin, however.
Reduced DsbA is also stabilized by a hydrogen bond
between the Cys30 thiolate and the mainchain amide of
His32. In addition, an electrostatic interaction is found in
the crystal structure of reduced DsbA between His32 and
Cys30, which can further stabilize the reduced form. In
thioredoxin, the residue equivalent to His32 is a highly
conserved proline. Unlike other residues, proline cannot
donate a mainchain hydrogen bond and, unlike histidine,
it cannot provide sidechain stabilization of the thiolate by
either electrostatic or hydrogen bond interactions. The
structure of reduced mutant T4 glutaredoxin [27], which,
like thioredoxin, also has the active-site sequence Cys–
Gly–Pro–Cys, has similar interactions at the active site as
those described for thioredoxin.
Discussion
The extremely oxidizing nature of DsbA has been pro-
posed to result from a conformational change of the two
domains upon active-site disulfide reduction (to relieve
strain in the oxidized form) or from the stabilization of
the active-site Cys30 thiolate in the reduced form. The
DsbA structures presented here show that hinge bending
motion of the two domains is permitted. This hinge
motion is not correlated with redox state, however, but is
a result of interactions at the putative peptide-binding
groove of DsbA. These results therefore suggest that
domain motion is not a valid model to explain the oxidiz-
ing properties of DsbA. The hinge bending motion of
DsbA could, however, be significant for substrate bind-
ing and/or for interactions with other proteins such as
DsbB [28].
In favour of the thiolate stabilization hypothesis, the crystal
structure of reduced DsbA reveals an intricate network of
favourable interactions with Cys30 thiolate that are not
present in oxidized DsbA. First, a hydrogen bond is formed
between the Cys30 thiolate and the sidechain thiol of
Cys33. The interatomic distance between the two sulfur
atoms in DsbA is relatively short (3.4–3.5 Å) compared
with the 3.8 Å hydrogen bonds observed in the neutron dif-
fraction study of L-cysteine [29] and in NMR [23] and
crystal structures [25] of reduced thioredoxin. This shorter
interaction could be an important component of both the
increased stabilization of reduced compared with oxidized
DsbA, as well as in the comparison of DsbA with related
redox proteins such as thioredoxin. The difference between
the sulfur–sulfur distance in reduced DsbA and thioredoxin
may not be significant, however, given the resolution of the
reduced DsbA structure (2.7 Å) and the use of different
refinement parameters.
Other interactions that stabilize the Cys30 thiolate of
reduced DsbA include two hydrogen bonds with mainchain
amides of His32 and Cys33. These interactions are within
the usual limits (3.3–3.6 Å) for S–N hydrogen bonds
[29–31]. The second of these hydrogen bonds is also pres-
ent in the oxidized structure of DsbA. However, hydrogen
bonds involving charged groups (such as the thiolate in the
reduced form) are more energetically favourable [32,33]
than those involving uncharged groups (such as the half-
cysteine of the disulfide bond). Thus, even though the
hydrogen bond with the Cys33 backbone amide may be
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present in both the oxidized and the reduced DsbA struc-
tures, it is likely to stabilize the reduced form more than it
stabilizes the oxidized form. The first of these two hydro-
gen bonds is not possible in thioredoxin, in which the
highly conserved histidine residue of DsbA is replaced
with the highly conserved proline of thioredoxin. Further-
more, the interaction between the reactive thiolate and
the mainchain amide of the Cys33 backbone amide is
observed in only one of three independently determined
reduced thioredoxin structures.
The histidine between the two cysteines is critical for the
stability profile of DsbA [18]. A histidine at the N terminus
of a helix, such as His32 in DsbA, is unfavourable because
of the interaction with the helix dipole [34]. His32,
however, forms at least two stabilizing interactions with the
thiolate in reduced DsbA, through the amide backbone
hydrogen bond and the sidechain electrostatic interaction.
Thus, His32 destabilizes the oxidized form far more than it
does the reduced form of DsbA. In comparison, the proline
at this position in thioredoxin does not interact unfavour-
ably with the helix dipole and cannot form the stabilizing
backbone hydrogen bond or sidechain electrostatic inter-
action with the thiolate in the reduced form. So, these
interactions that significantly effect the stability profile of
DsbA are absent in the reducing protein thioredoxin.
Finally, the interaction between the active-site thiolate
and the partial positive charge of the helix dipole also
favours reduced over oxidized DsbA. This interaction is
possible for all thioredoxin-like redox proteins, however,
because a cysteine at the beginning of a helix forms part of
the conserved active-site sequence. Indeed, a cysteine at
the N terminus of any helix is highly favoured as a result
of the interaction with the helix dipole [35] and leads to a
reduction in the cysteine pKa compared with the normal
value (~9). All four of the thioredoxin family of redox pro-
teins exhibit a reduced pKa for this cysteine, although the
pKa of ~6–7 for thioredoxin [36–38] is somewhat higher
than the pKa values of 3.5–4.5 measured for DsbA [17,18],
glutaredoxin [39–41] and PDI [19].
For the thioredoxin-fold redox proteins, the common stabi-
lizing interactions for cysteine thiolate are therefore the
interaction with the helix dipole and the hydrogen bond
formation with the other active-site cysteine. These may be
the only stabilizing interactions for thioredoxin. For DsbA,
PDI and glutaredoxin there must be additional stabilizing
interactions to account for the lower cysteine pKa. For
DsbA, the additional stability could derive from a combina-
tion of the shorter hydrogen bond formed with Cys33, the
two additional hydrogen bonds formed with mainchain
amides in the active site and the electrostatic interaction
with His32. These same factors could also account for the
lowered pKa of PDI, which has a histidine at the equivalent
position to DsbA.
Recently, we learned that an NMR solution structure of
reduced DsbA has been determined that shows a larger
hinge motion than described here [42]. This may be a
result of the differing conditions under which the struc-
tures were determined. The reduced NMR structure was
determined at pH 3.7 (a pH at which many acidic groups
including Cys30 are most likely to be partially charged),
whereas the crystal structure was determined at the some-
what more physiological pH of 5.6 (at which Cys30 is most
likely to be fully ionized). The NMR structure determina-
tion of oxidized DsbA at pH 3.7 is underway (HJ Schirra,
R Glockshuber et al., personal communication) and will
allow a better understanding of the difference between
the NMR and crystal structures of reduced DsbA.
Biological implications
Divergent protein function within a similar protein fold
is a repeating theme in biology. A detailed knowledge of
how the function of structurally related proteins is con-
trolled has broad implications for other systems. Within
the family of thioredoxin fold proteins there exists a
wide diversity of properties and functions, generally
involving cysteine chemistry. Of the redox proteins in
this family —including thioredoxin and DsbA —the
redox strengths vary by a factor of 100,000. The most
oxidizing of these proteins, the bacterial protein-folding
factor DsbA, is unusual in that the redox state in which
the two active-site cysteines are reduced is significantly
more stable than the oxidized (or disulfide) form. Never-
theless, the thioredoxin folds of the highly oxidizing
DsbA and the highly reducing thioredoxin are struc-
turally equivalent.
Analysis of the structures of these two proteins can
provide information about the factors that might affect
function. A significant structural difference is the pres-
ence of two domains in DsbA, but only a single domain
in thioredoxin. The possibility that domain flexibility in
DsbA might account for its extremely oxidizing nature
was investigated. We observed that hinge bending does
occur between the two domains of DsbA. This confor-
mational change was not correlated with redox state,
however, and so does not contribute to the oxidizing
nature of DsbA. Instead, domain motion may be required
to facilitate protein–protein interactions such as those
that occur with unfolded polypeptide substrate and/or
with the re-oxidizing protein DsbB [28]. 
The greater stability of reduced over oxidized DsbA
appears to be a result of a greater stabilization of the
reactive thiolate (compared with the disulfide form) at
the active site. This is affected by a network of hydrogen
bond and electrostatic interactions that favour the for-
mation of the Cys30 thiolate. These interactions include
hydrogen bonds between the thiolate and the Cys33
thiol, the backbone nitrogen of Cys33 and the backbone
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nitrogen of His32. The Cys30 thiolate can also form a
favourable electrostatic/hydrogen bond interaction with
the sidechain of His32. In addition, the thiolate of
reduced DsbA can interact favourably with the helix
dipole. These favourable interactions are removed in oxi-
dized DsbA when Cys30 forms one half of the active-site
disulfide. In contrast, the unfavourable interaction
between His32 and the helix dipole is present in both the
oxidized and reduced forms of DsbA.
Materials and methods
Expression, purification and crystallization
Recombinant DsbA was expressed and purified in E. coli as described
previously [43]. Samples for crystallization were purified by FPLC using
an HR 5/5 Mono Q column and concentrated to 40–60 mg/ml. Purity
was estimated to be > 95% as judged by FPLC, SDS-PAGE and mass
spectrometry.
Reduced DsbA (RED) was crystallized by the dialysis method; 3 µl
each of protein (60 mg/ml) and precipitant were dispensed into 5 µl
dialysis buttons (obtained from Hampton Research, California). We
found that using a total volume of 6 µl rather than 5 µl helped prevent
air bubbles forming when the dialysis buttons were sealed. Spectra/
Por CE dialysis membrane, with a 15,000 Da molecular weight cut off,
was used to seal the dialysis buttons. After sealing, the dialysis button
was placed in a well of a Linbro tissue culture plate and immersed in
1.5 ml of precipitant solution. The precipitant solution consisted of
0.2 M ammonium acetate, 0.1 M sodium citrate pH 5.6, 30% w/v poly-
ethylene glycol 4 K and 40 mM dithiothreitol (DTT). The wells were
then sealed with cover slips and white soft paraffin. Reduced DsbA
crystals of average size 0.3 × 0.1 × 0.1 mm3 appeared within 2–3 days.
Additional DTT (10 µl of a 1 M stock solution) was added to the precip-
itant solution every 2–3 days to ensure DsbA was maintained in the
reduced form. Isoelectric focusing gels of samples taken from the equi-
librated protein in the dialysis button confirmed that DsbA was in the
reduced form.
Crystallization and structure determination of the original crystal form of
oxidized DsbA (OX1) has been described in detail previously [44].
Briefly, the crystals are grown by hanging drop vapour diffusion using a
precipitant of 25% polyethylene glycol 8 K in 0.1 M cacodylate buffer,
pH 6.5. Two new crystal forms of oxidized DsbA were prepared for this
work. One (OXR) was produced by dialysis in the same way as
reduced DsbA crystals, but was oxidized over a period of two months
by withholding addition of DTT after crystallization. The other oxidized
DsbA crystal form (OX2) was grown using the hanging drop vapour dif-
fusion method. Drops of 4 µl were used (2 µl each of 40 mg/ml DsbA
and reservoir). The reservoir consisted of 27% polyethylene glycol 4 K
in 0.1 M acetate buffer, pH 5.0. Crystals grew within 1–2 weeks and
were of average size 0.5 × 0.4 × 0.2 mm3.
Crystallographic data measurement 
Unit cell, space group and crystallographic statistics for data from each
of the three new crystal forms of DsbA are presented in Table 1. For
OX2, OXR and RED, data were measured at 16°C using a RAXIS-IIC
image plate area detector with RU-200 rotating anode X-ray generator
operated at 46 kV and 60 mA. The crystal to detector distance was
100 mm and each frame was exposed for 30 min with an oscillation
range of 2°. Frames were integrated, scaled and merged using the
DENZO and SCALEPACK programs [45].
Reduced DsbA crystals are radiation sensitive, resulting in a reduction
of diffraction data quality over time. We have not been able to over-
come this problem using cryogenic data measurement because suit-
able cryoprotectant solution conditions and soaking regimes (which
do not crack crystals, or increase mosaicity to > 1°) have not been
identified.
Structure determination
The structure of OX1 (PDB accession code 1FVK) was used as the
search model to solve the structures of OX2 and RED by molecular
replacement [46] using X-PLOR v3.1 [47] and v3.851, respectively.
The structure of OXR was solved by difference Fourier refinement from
RED. R-free cross validation using 10% of reflections [48] was used
throughout all the structure determinations and refinements. 
The calculated solvent content of the reduced DsbA crystal form indi-
cated that two DsbA molecules were present in the asymmetric unit.
The two highest peaks in the rotation function were at (θ1 = 343.3°,
θ2 = 42.5°, θ3 = 287.9°) and (θ1 = 173.0°, θ2 = 60.0°, θ3 = 93.0°) and
were 4.1σ and 3.7σ above the mean, respectively. The next highest
peak was 3.1σ above the mean. After PC-refinement [46], the two top
peaks had the highest correlation coefficients of 0.1183 and 0.1277,
respectively. For peak 1, the translation search calculated using X-PLOR
gave a maximum at x = 17.47 Å, y = 7.47 Å and z = 27.9 Å with a corre-
lation coefficient of 0.291 (7.0σ above the mean). The translation search
with peak 2 from the rotation function gave a maximum at x = 13.44 Å,
y = 39.20 Å and z = 12.10 Å, with a correlation coefficient of 0.333
(8.3σ above the mean). The common origin of the second molecule rela-
tive to the first was located at (1/2,0,0). When the two molecules were
positioned in the asymmetric unit, a correlation coefficient of 0.5704
was obtained. Using all data in the resolution range 10–2.7 Å, the
R-factor for this solution was 0.410 and R-free was 0.411.
For OX2, the rotation and translation searches were performed using
reflections in the resolution range 15–4 Å. The initial rotation search
did not find a clear solution for the single molecule in the asymmetric
unit. After PC refinement, however, a peak with a correlation coefficient
of 0.331 was obtained at (θ1 = 221.9°, θ2 = 44.5°, θ3 = 155.8°). The
next highest peak had a correlation coefficient of < 0.120. The
maximum in the translation function was at x = 0.45, z = 0.40 (in frac-
tional coordinates) with a correlation coefficient of 0.607 or 8.1σ above
the mean. The initial R-factor and R-free values for reflections in the
range 10–3 Å were 0.451 and 0.476, respectively. 
Crystallographic refinement 
Refinement was performed using X-PLOR v3.1 for OX2 and v3.851 for
RED and OXR and was guided by the use of R-free [49]. Rigid body
refinement of both RED and OX2 structures was performed by allow-
ing the helical and thioredoxin domains to refine independently. In both
cases, this resulted in a significant reduction of R-factor and R-free of
2–4%. Positional and individual B-factor refinement were performed
using standard protocols within X-PLOR. For RED (anisotropic overall
B-factor correction) and OX2 structures, bulk solvent correction as
implemented in X-PLOR was also used. Refinement weights were
chosen that strongly restrained the geometric parameters to prevent
overfitting of the crystallographic data. Model building was performed
using the program O [50]. Waters were included only where spherical
density was present above 1.0σ in the 2Fo–Fc map and above 3.0σ in
the Fo–Fc map, and where the water made stereochemically reason-
able hydrogen bonds. Crystallographic and geometric statistics for the
final refined models of the DsbA crystal structures are given in Table 2.
For reduced DsbA, residues 29–34 at the active site (including the two
cysteines Cys30 and Cys33) of each of the two molecules in the asym-
metric unit were excluded from initial crystallographic refinement. After
rigid-body refinement, the electron density maps were of sufficient
quality to unambiguously model all the active-site residues 29–34,
including the reduced conformations of Cys30 and Cys33. The final
2Fo–Fc electron density map of the active site of reduced DsbA is
shown in Figure 2. The refined model of reduced DsbA and oxidized
DsbA in the reduced crystal form excludes mobile residues at the N and
C termini (Ala1, Gln2 and Lys189 in both molecules).
In all the protein crystal structures, residues with poorly defined sidechain
density were modeled as alanine. For reduced DsbA, these residues are
Lys7, Lys14, Lys47, Glu52, Lys55, Lys98, Glu120, Lys132, Asp167 and
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Lys183 from both REDA and REDB, plus from REDA only Gln146,
Lys158, Ser169, Val173, Gln177 and Tyr184 and from REDB only
Glu13, Lys48, Arg103, Ser106, Gln137, Gln164, Gln176 and Ser186.
Similarly, the following residues were modeled as alanine in OXR: for
both molecules Lys7, Lys14, Lys47, Lys49, Lys55, Lys87, Lys118,
Glu120 and Lys188; plus from OXRA only Asp5, Glu38, Ile42, Lys48,
Val54, Lys70, Lys78, Gln137, Arg148, Ser169, Asn170, Met171,
Asp172, Val173, Gln177, Tyr184, Ser186 and Gln187; and from OXRB
only Gln2, Tyr9, Glu13, Asp67, Gln100, Arg103, Ser106, Asp107,
Arg109, Ile117, Glu121, Ser133, Gln146, Lys158 and Gln164.
For OX2, the final model includes all residues except the C-terminal
Lys189. The sidechains of residues Glu4, Glu13, Lys48, Lys98,
Lys118, Glu120, Lys132, Gln146 and Lys183 were modeled as
alanine because of poorly defined sidechain density. Residues Glu85,
Ser106, Ser133 and Ser186 were modeled with two conformations,
each of half occupancy.
Structure validation and analysis
The final structures were validated using the program PROCHECK
[51]. The structures were superimposed and rmsd calculations were
performed using the program O [50]. An analysis of the hinge angle
between the two domains of DsbA was performed using the program
HINGEFIND [22]. 
Accession numbers
Coordinates of OX2, OXR and RED have been deposited at the PDB
[26] with accession codes 1A2J, 1A2M and 1A2L, respectively. Struc-
ture factors have also been deposited. Coordinates of the 1.7 Å refined
crystal structure of oxidized DsbA in the C2 crystal form (OX1) used in
this analysis are available from the PDB with accession code 1FVK.
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